Eur Rev Med Pharmacol Sci 2019; 23 (19): 8354-8359
DOI: 10.26355/eurrev_201910_19146

Endoscopic submucosal dissection for superficial premalignant and malignant epithelial neoplasms of the digestive tract: a real-life experience in Italy

N. Pagano, L. Frazzoni, M. La Porta, L. Fuccio, F. Bazzoli, R.M. Zagari

Gastroenterology Unit, Department of Digestive Disease, S. Orsola-Malpighi Hospital, Bologna, Italy. roccomaurizio.zagari@unibo.it


OBJECTIVE: Endoscopic submucosal dissection (ESD) is a technique for en bloc resection of neoplastic lesions of the digestive tract. Endoscopic submucosal dissection was developed in Asia, and data from Western countries are scarce. Our study aimed to assess the efficacy and safety of ESD for resection of superficial premalignant and malignant epithelial neoplasms in a tertiary center in Italy.

PATIENTS AND METHODS: All patients with gastrointestinal lesions who underwent ESD between January 2013 and December 2018 in our center were retrospectively evaluated. Technical success, en bloc, R0, curative resection, and complication rates were assessed.

RESULTS: A total of 107 lesions (stomach, no.=41; rectum, no.=32; colon, no.=28; esophagus, no.=5; duodenum, no.=1) were resected by ESD in 93 patients. Endoscopic submucosal dissection was technically successful in 99.1% (106/107) of lesions. Among the 90 superficial premalignant and malignant epithelial neoplasms, en bloc, and R0 resection rates were 97.8% (no.=88) and 75.6% (no.=68), respectively. Major complications occurred in 9.3% (10/107) of cases: 4 (3.7%) were perforations and 6 (5.6%) were major bleedings. All complications, but two which needed surgery, were managed endoscopically.

CONCLUSIONS: Our study shows that ESD is a feasible, effective, and safe technique in a Western country.

Free PDF Download

To cite this article

N. Pagano, L. Frazzoni, M. La Porta, L. Fuccio, F. Bazzoli, R.M. Zagari
Endoscopic submucosal dissection for superficial premalignant and malignant epithelial neoplasms of the digestive tract: a real-life experience in Italy

Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 19
Pages: 8354-8359
DOI: 10.26355/eurrev_201910_19146